Tritace Protect expanding presence in cardiovascular market

Handok Pharm said on March 16 that its Tritace Protect (ramipril) 10mg tablet has been expanding their presence in the domestic cardiovascular market since its launching on March of Last year.

Tritace Protect has been successfully landed on 130 general hospitals across the country, exceeding 2 million tablets for only one year, according to the company.

Ramipril is an angiotensin-converti...